Top of page

Student/Staff Portal
Global Site Navigation

School of Medical and Health Sciences

Local Section Navigation
You are here: Main Content
  • Dr Hao Luo

    Dr Hao Luo

Related Contents

Dr Hao Luo

Post Doctoral Research Fellow

Staff Member Details
Email: h.luo@ecu.edu.au
ORCID iD: https://orcid.org/0000-0001-5181-7529

Co-lead, Exercise and Gastrointestinal Cancers Research Group.

Dr. Luo is a Post-Doctoral Research Fellow in the Exercise Medicine Research Institute. His research focuses on the role of clinical exercise and sport-based interventions in patients with cancer during treatment, in particular in patients with pancreatic cancer during chemotherapy.

Professional Memberships

  • Exercise and Sports Science Australia (ESSA)
  • The Australasian Gastro-Intestinal Trials Group (AGITG)

Research Areas and Interests

  • Potential of exercise medicine as an adjunct to chemotherapy in pancreatic cancer
  • Role of sport-based interventions in cancer care
  • Reporting of adverse events in exercise oncology

Awards and Recognition

  • The 2022 Rowe Scientific Prize for Excellence in a Scientific Discipline ($1,000)
  • The ECU Early and Mid-Career Researcher Conference Funding
  • The ECU Exercise Medicine Research Institute 2024 Travel Award

Research funding

  • 2022-2026: Medical Research Future Fund (MRFF): 2021 Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Grant ($561,910)
  • 2019-2023: The ECU School of Medical and Health Sciences PhD Scholarship ($99,470)
  • 2017-2018: The China Scholarship Council (CSC) Funding for Visiting Research Scholar ($22,600)

Qualifications

  • Doctor Of Philosophy, Edith Cowan University, 2023.
  • Master of Education (Theory of Sports Pedagogy and Training), China (excludes SARs and Taiwan), 2009.

Research Outputs

2025

Journal Articles

  • Markarian, A., Taaffe, D., Bettariga, F., Luo, H., Galvao, D., Cochrane Wilkie, J., McIntyre, C., Newton, R. (2025). Bone mineral density in childhood cancer survivors during and after oncological treatment: A systematic review and meta-analysis. Osteoporosis International, 36(5), 767-777. https://doi.org/10.1007/s00198-025-07458-5.
  • Taaffe, D., Newton, R., Chambers, S., Nelson, C., Spry, N., Luo, H., Schumacher, O., Joseph, D., Gardiner, R., Hayne, D., Galvao, D. (2025). Immediate Versus Delayed Exercise on Health-related Quality of Life in Patients Initiating Androgen Deprivation Therapy: Results from a Year-long Randomised Trial. European Urology Oncology, 8(2), 387-393. https://doi.org/10.1016/j.euo.2024.09.012.
  • Galvao, D., Newton, R., Taaffe, D., Cormie, P., Schumacher, O., Nelson, C., Gardiner, R., Spry, N., Joseph, D., Tang, C., Luo, H., Chee, R., Hayne, D., Chambers, S. (2025). Exercise and Psychosexual Education to Improve Sexual Function in Men With Prostate Cancer: A Randomized Clinical Trial. JAMA Network Open, 8(3), Article number e250413. https://doi.org/10.1001/jamanetworkopen.2025.0413.
  • Luo, H., Bergerot, P., Galvao, D., Jeon, J., Mustian, K., Newton, R., Pillay, L., Wiskemann, J., Schmitz, KH. (2025). International perspectives on exercise oncology: current state, challenges, and opportunities for future development. Journal of the National Cancer Institute Monographs, 2025(71), 325–333. https://doi.org/https://doi.org/10.1093/jncimonographs/lgaf028.

2023

Journal Articles

  • Luo, H., Galvao, D., Newton, R., Tang, C., Spry, N., Taaffe, D. (2023). Multimodal Exercise in Older Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy: A Case Series Examining Feasibility and Preliminary Efficacy. European Journal of Cancer Care, 2023(2023), article number 1179848. https://doi.org/10.1155/2023/1179848.
  • Luo, H., Galvao, D., Newton, R., Tang, C., Hart, N., Singh, F., Dean, A., Jasas, K., Johansson, M., Yusoff, I., Spry, N., Taaffe, D. (2023). Evaluation of a Clinic-Based Exercise Program in Patients with Pancreatic Cancer Undergoing Nonsurgical Treatment. Medicine and Science in Sports and Exercise, 55(1), 9-19. https://doi.org/10.1249/MSS.0000000000003019.

2022

Journal Articles

  • Wang, T., Zhang, Y., Taaffe, D., Kim, J., Luo, H., Yang, L., Fairman, C., Qiao, Y., Newton, R., Galvao, D. (2022). Protective effects of physical activity in colon cancer and underlying mechanisms: A review of epidemiological and biological evidence. Critical Reviews in Oncology/Hematology, 170(February 2022), Article number 103578. https://doi.org/10.1016/j.critrevonc.2022.103578.
  • Luo, H., Schumacher, O., Galvao, D., Newton, R., Taaffe, D. (2022). Adverse Events Reporting of Clinical Trials in Exercise Oncology Research (ADVANCE): Protocol for a Scoping Review. Frontiers in Oncology, 12(16 February 2022), Article number 841266. https://doi.org/10.3389/fonc.2022.841266.

2021

Journal Articles

  • Luo, H., Galvao, D., Newton, R., Tang, C., Dean, A., Jasas, K., Johansson, M., Yusoff, I., Spry, N., Taaffe, D. (2021). Feasibility and efficacy of a multi-component exercise medicine program in pancreatic cancer patients undergoing neoadjuvant therapy (the EXPAN trial): study protocol of a dual-centre, two-armed phase I randomised controlled trial. BMJ Open Gastroenterology, 8(1), Article number e000642. https://doi.org/10.1136/bmjgast-2021-000642.
  • Schumacher, O., Luo, H., Taaffe, D., Galvao, D., Tang, C., Chee, R., Spry, N., Newton, R. (2021). Effects of exercise during radiotherapy on physical function and treatment-related side effects in men with prostate cancer: A systematic review and meta-analysis. International Journal of Radiation: Oncology - Biology - Physics, 111(3), 716-731. https://doi.org/10.1016/j.ijrobp.2021.06.034.
  • Luo, H., Galvao, D., Newton, R., Lopez Da Cruz, P., Tang, C., Fairman, C., Spry, N., Taaffe, D. (2021). Exercise medicine in the management of pancreatic cancer: A systematic review. Pancreas, 50(3), 280-292. https://doi.org/10.1097/MPA.0000000000001753.

Research Projects

  • A Multicomponent Exercise Medicine Programme in Patients with Pancreatic Cancer Undergoing Neoadjuvant Therapy (the EXPAN trial): A Two-armed Phase I Randomised Controlled Trial, National Health and Medical Research Council, MRFF - Clinical Trials Activity (Rare Cancers, Rare Diseases and Unmet Need) Initiative, 2022 ‑ 2027, $561,910.
  • Improving clinical outcomes in Western Australian women with endometrial cancer: Neoadjuvant exercise and nutrition therapy prior to surgery, Cancer Council of WA Inc, Suzanne Cavanagh Early Career Investigator Grants, 2024 ‑ 2025, $34,834.
Skip to top of page